The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
SPINRAZA nusinersen (as heptadecasodium) 12 mg/ 5 mL solution for injection vial (282522)
ARTG Name
SPINRAZA nusinersen (as heptadecasodium) 12 mg/ 5 mL solution for injection vial
Product name
SPINRAZA nusinersen (as heptadecasodium) 12 mg/5mL solution for injection vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
nusinersen heptadecasodium
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information